Research Article

Investigation of Antileishmanial Activities of Acridines Derivatives against Promastigotes and Amastigotes Form of Parasites Using Quantitative Structure Activity Relationship Analysis

Table 1

Chemical structure and antileishmanial activities of studied compounds (see Figure 8).

Number R1R2R3R4R5R6R7
PROAMA

1HNHCOCH3HHHNHCOCH3H−2.533−0.653
2HNHCOC2H5HHHNHCOC2H5H−2.204−0.886
3HNHCOC3H7HHHNHCOC3H7H−1.669−1.107
4HNHCOphHHHNHCOPhH−0.634−0.041
5HNHCO-p-PhClHHHNHCO-p-PhClH0.699
6HNHCO-p-PhFHHHNHCO-p-PhFH−0.2301.523
7HNHCO-p-PhOMeHHHNHCO-p-PhOMeH−0.681−0.041
8HNHCO-m,p-Ph(OMe)2HHHNHCO-m,p-Ph(OMe)2H−1.2070.097
9HNHCOMeHHHNHCOphH−2.270Tox
10HNHCOMeHHHNHCO-p-PhClH−1.061−0.462
11HNHCOMeHHHNHCO-p-PhFH−2.1230.174
12HNHCOMeHHHNHCO-p-PhOMeH−1.939Tox
13HNHCOMeHHHNHCO-m,p-Ph(OMe)2H−0.114
14HHCH3NH2OMeHH 0.3010.398
15HHCH2OHNH2OMeHH−0.732−0.613
16HHCH2BrNH2OMeHH−0.556−0.663
17HH(CH2)2OCOOMeNH2OMeHH−0.380−0.114
18HH(CH2)2OCO(CH2)2CH3NH2OMeHH−0.491−0.398
19HH(CH2)2OCOCH2CH(CH3)2NH2OMeHH−0.342Tox
20HH(CH2)2OCOPhNH2OMeHH0.3980.699
21HH(CH2)2OCOPhFNH2OMeHH−0.1140.222
23HH(CH2)2OCOPhOMeNH2OMeHH−0.279 Tox
24HHCH3ClOMeHH−0.041−0.362
25HHCH2OHClOMeHH−2.262−0.959
26HHCH2BrClOMeHH−1.703−1.170
27HH(CH2)2OCOOMeClOMeHH−2.178−1.877
28HH(CH2)2OCO(CH2)2CH3ClOMeHH−1.707−1.628
29HH(CH2)2OCOCH2CH(CH3)2ClOMeHH−1.446−1.561
30HH(CH2)2OCOPhClOMeHH−2.135Tox
31HH(CH2)2OCOPhFClOMeHH−2.295−1.645
32HH(CH2)2OCOPhClClOMeHH−2.194−2.191
33HH(CH2)2OCOPhOMeClOMeHH−2.098−2.088
34CH2NH2HHHHHH−0.230−0.531
35CH2OHHHHHHHTox−1.515
36CH2NHCO(CH2)3ClHHHHHH−1.655−1.427
37CH2OCO(CH2)3ClHHHHHH−2.200−2.185
38CH2NHCOCH=CH2HHHHHH−2.245−0.833
39CH2OCOCH=CH2HHHHHH−1.464
40CH2NHCOPhHHHHHH−1.654−1.121
41CH2OCOPhHHHHHH−1.885Tox
42CH2NHCO-p-PhFHHHHHH−1.815
43CH2OCO-p-PhFHHHHHH−1.741Tox
44CH2NHCO-p-PhClHHHHHHTox−1.004
45CH2OCO-p-PhClHHHHHH−1.790−1.433
46CH2NHCO-p-PhOMeHHHHHH−1.513−0.973
47CH2OCO-p-PhOMeHHHHHH−1.471−0.869
48CH2NHCO-p-PhNMe2HHHHHH−1.539−0.672
49CH2OCO-p-PhNMe2HHHHHH−1.819Tox
50CH2NH2HHHHHCH2NH2−0.820−0.531
51CH2OHHHHHHCH2OHTox0.222
52CH2NHCO(CH2)3ClHHHHHCH2NHCO(CH2)3Cl−0.663−0.813
54CH2NHCOCH=CH2HHHHHCH2NHCOCHCH2−1.061Tox
56CH2NHCOPhHHHHHCH2NHCOPh−0.556−1.236
57CH2OCOPhHHHHHCH2OCOPhTox−0.716
58CH2NHCO-p-PhFHHHHHCH2NHCO-p-PhF−0.756−0.255
60CH2NHCO-p-PhClHHHHHCH2NHCO-p-PhCl−1.562
62CH2NHCO-p-PhOMeHHHHHCH2NHCO-p-PhOMe−1.797Tox
63CH2OCO-p-PhOMeHHHHHCH2OCO-p-PhOMeTox−1.825
64CH2NHCO-p-PhNMe2HHHHHCH2NHCO-p-PhNMe2−0.940−0.724
65CH2OCO-p-PhNMe2HHHHHCH2OCO-p-PhNMe2Tox−1.667

Toxic: toxicity observed on human macrophages at concentrations that did not display antileishmanial activity; -p-: para; -m-: meta; pIC50 = −log (IC50); pIC50 AMA: antileishmanial activity against amastigotes parasite form; pIC50 PRO: antileishmanial activity against promastigotes parasite form.